Deadline: 20-Nov-2025
The DKMS John Hansen Research Grant is currently seeking applications to provide financial support to promising young researchers to advance the understanding of complications and therapeutic strategies in the context of hematological diseases.
With a total value of up to EUR 240,000, the grant is designed to support promising scientific projects over a period of three years. Recipients can receive an annual budget of EUR 80,000, allowing them to focus on their research without financial constraints.
This international grant is open to applicants from all countries, provided they have earned a doctoral degree such as a PhD or MD within the last ten years from the start date of the grant call. Those who have experienced career interruptions due to family care responsibilities, health issues, or mandatory service may apply for an extension to the eligibility window. Past recipients of the grant are not eligible to apply again, ensuring the opportunity is extended to new researchers.
Applicants must be affiliated with a qualified host institution and have a designated supervisor with experience in the research topic. The host institution must be eligible under German tax law, typically including public universities, government-funded institutions, and certain non-profit organizations. The funds are disbursed directly to the institution, which is required to manage them through a separate account or cost center specifically set up for the project.
Once awarded, the funding is disbursed in Euros and must be used within two calendar years from the date of each payment. Any costs related to currency conversion or bank transfer fees will not be reimbursed. At the end of each funding year, recipients must submit a detailed financial report to verify appropriate use of the grant. The release of funding for the following year is conditional on the approval of this documentation.
The DKMS John Hansen Research Grant not only provides financial support but also represents an opportunity for young researchers to contribute to meaningful advances in medical science. It is a chance to develop their careers, collaborate with leading experts, and potentially make a lasting impact in the fight against blood cancer and related diseases.
For more information, visit DKMS.